If the situation is as I read it: - Importing drugs from countries with reliable drug regulatory infrastructure would have substantial benefits, including a ch

If the situation is as I read it: - Importing drugs from countries with reliable drug regulatory infrastructure would have substantial benefits, including a check on cost (sorely needed), and improved availability of less profitable drugs - Other similar countries are doing this without seeing measurable negative health outcomes then getting hung up on this 'major concern' that seems to have been rendered moot elsewhere makes most people worse off. Mentioning the existence of potential (and unlikely?[1]) downsides is not an adequate cost-benefit analysis. [1] not that it's unlikely that there will be people who try to take advantage of the system, but it seems unlikely that given appropriate regulatory care, the downsides will be unmanageable to the extent that they cause the change to allow drug imports to have an overall negative impact. [edited for clarity, including the addition of the footnote]